Abstract:Abstract Background Although the aberrant expression and function of most Ca 2+ -permeable channels are known to promote gastrointestinal tumors, the association between transient receptor potential vanilloid receptor 1 (TRPV1) channels and gastric cancer (GC) has not yet been explored. Herein, we sought to determine the role of TRPV1 channels in the development of GC and to elucidate the underlying molecular mechanisms involved therein. Methods Immunohistochemistry, qPCR, Western blot, immunofluorescence assays were used to detect the mRNA and protein expression of TRPV1 in GC cells and tissues, and the clinical significance of TRPV1 in GC was also studied by clinicopathologic analysis. CCK8, colony formation, flow cytometry assays were used to detect the proliferation and survival of GC cells, while transwell assay was used to detect migration and invasion of GC cells in vitro. Tumor xenograft and peritoneal dissemination assays in nude mice were used to examine the role of TRPV1 in GC development in vivo. Results TRPV1 expression was significantly downregulated in human primary GC tissues compared to their adjacent tissues. The decreased expression of TRPV1 proteins in GC tissues was positively correlated with tumor size, histological grade, lymphatic metastasis, clinical stage, and was strongly correlated with poor prognosis of GC patients. Moreover, the expression of TRPV1 was closely correlated with Ki67, VEGFR, and E-cadherin, all of which are the well-known cancer markers for proliferation and metastasis. TRPV1 proteins were predominately expressed on the plasma membrane in several GC cell lines. TRPV1 overexpression blocked cell cycle at G1 phase to inhibit GC cell proliferation and attenuated migration and invasion of GC cells in vitro, but TRPV1 knockdown increased these parameters. TRPV1 significantly reduced gastric tumor size, number and peritoneal dissemination in vivo. Mechanistically, TRPV1 overexpression in GC cells increased [Ca 2+ ] i , activated CaMKKβ and AMPK phosphorylation, and decreased expression of cyclin D1 and MMP2, while TRPV1 knockdown induced the opposite effects. Conclusions TRPV1 uniquely suppresses GC development through a novel Ca 2+ /CaMKKβ/AMPK pathway and its downregulation is correlated with poor survival of human GC patients. Thus, TRPV1 upregulation and its downstream signaling may represent a promising target for GC prevention and therapy.

[Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].

The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies

Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancer

The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives

The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review

Gut microbiota and its therapeutic implications in tumor microenvironment interactions

Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy

Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.

Public lacks knowledge on chronic kidney disease: telephone survey.

The role of transient receptor potential channels in metastasis

Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Emerging roles of the gut microbiota in cancer immunotherapy

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy

Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application

The role of TRPV1 ion channels in the suppression of gastric cancer development

The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review

On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications